AK
Ashok Khandu Shelke
About Ashok Khandu Shelke
Data last updated:
Ashok Khandu Shelke is a Director at Mediswan Lifesciences Private Limited (since 2023) and Designated Partner at Medmart Pharma Llp (since 2016). The companies operate in Paper and Pharma. The largest current company by reported revenue is Mediswan Lifesciences Private Limited at ₹4.1 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 21 Apr 2023 | 2023 | ₹4.1 Lakh (FY 2025) | Active | |
| Designated Partner | 10 Mar 2016 | 2016 | Active |
Board colleagues of Ashok Khandu Shelke
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bhikaji Jagannath Sanap | 10127518 | Mediswan Lifesciences Private Limited | Director |
| Satish Khandu Shelke | 07424289 | Mediswan Lifesciences Private Limited , Medmart Pharma Llp | Director |
| Sharad Ramdas Gite | 10127517 | Mediswan Lifesciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ashok Khandu Shelke
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ashok Khandu Shelke
Ashok Khandu Shelke currently holds 2 directorships: Mediswan Lifesciences Private Limited (Director, since 21 Apr 2023, revenue ₹4.1 Lakh (FY 2025)); Medmart Pharma Llp (Designated Partner, since 10 Mar 2016).
Ashok Khandu Shelke was first appointed on 10 Mar 2016 as Designated Partner at Medmart Pharma Llp. The most recent appointment on record is 21 Apr 2023 at Mediswan Lifesciences Private Limited.
The current boards of Ashok Khandu Shelke's companies include Bhikaji Jagannath Sanap (Mediswan Lifesciences Private Limited), Satish Khandu Shelke (Mediswan Lifesciences Private Limited), Sharad Ramdas Gite (Mediswan Lifesciences Private Limited).